Firm
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
AI patents and dairy trademarks are at the centre of two judgments to be handed down next week
Sponsored
Sponsored
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners takes a closer look at how the Japanese government’s approach to the strategic acquisition and utilisation of SEPs will change -
Sponsored by Vivien Chan & CoExperts from Vivien Chan & Co report on significant developments from the IP world across China and the Asia-Pacific
-
Sponsored by AJ ParkAJ Park explains the key takeaways from a recent case involving trademark disclaimers
-
Sponsored by Bird & BirdPeter Brownlow and Mark Hilton of Bird & Bird consider the impact of Brexit on international IP cases heard in England
-
Sponsored by LexOrbisManisha Singh and Simran Bhullar of LexOrbis take a look at the surprising court record of a persistent offender deceptively targeting Indian health and beauty brands
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies
